fluorodeoxyglucose f18 has been researched along with Endocrine System Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ansquer, C; Bera, G; Bergeret, S; Chanson, P; Charbit, J; Lussey-Lepoutre, C | 1 |
| Al-Nahhas, A; Rubello, D | 1 |
1 review(s) available for fluorodeoxyglucose f18 and Endocrine System Diseases
| Article | Year |
|---|---|
Novel PET tracers: added value for endocrine disorders.
Topics: Dihydroxyphenylalanine; Endocrine System Diseases; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Neuroendocrine Tumors; Positron-Emission Tomography; Radiopharmaceuticals | 2019 |
1 other study(ies) available for fluorodeoxyglucose f18 and Endocrine System Diseases
| Article | Year |
|---|---|
Nuclear medicine in endocrinology.
Topics: Endocrine System Diseases; Endocrinology; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Nuclear Medicine; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Diseases; Tomography, Emission-Computed, Single-Photon | 2008 |